¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Contact with and exposure to communicable diseases"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® Dilatation and Curettage(D & C) ÇÑ±Û Àڱñܾ¼ú, ÀڱøñÈ®Àå
¼³¸í   
  ÀÚ±ÃÀ̶õ Å¾ư¡ ¼öŵǾ ºÐ¸¸Àü±îÁö ¹ßÀ°ÇÏ°í ¼ºÀåÇϴ °ø°£ÀÌ´Ù. Àڱüӿ¡ º´º¯ÀÌ ÀÖ¾î ÀÓ½ÅÀÌ °è¼ÓµÉ ¼ö ¾ø°Å³ª ¾Æ´Ï¸é ´Ù¸¥ ÀÌÀ¯·Î ÀӽŵǾî Àִ Å¾Ƹ¦ Á¦°ÅÇϰíÀÚ ÇÒ °æ¿ì¿¡ »ç¿ëµÇ´Â ¹æ¹ýÀÌ´Ù. ¿©±â¼­ ±Ü¾î³»±â À§ÇÏ¿©´Â ¿ì¼± ÀÚ±ÃÀÇ ÀÔ±¸¿¡ ÇØ´çÇϴ ÀڱøñÀ» È®Àå½ÃÄѾߠÇÑ´Ù. ¿©±â¿¡´Â ±Þ¼ÓÈ÷ È®ÀåÀ» ½ÃµµÇϴ ¹ý°ú ¼­¼­È÷ È®ÀåÀ» ½ÃµµÇϴ 2°¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ÀڱøñÀ» ±Þ¼ÓÈ÷ È®ÀåÇÒ ¶§´Â Çì°¡¸£ ¸ñ°üÈ®Àå±â(Hegar's dilatator)¸¦ »ç¿ëÇÑ´Ù. À̰ÍÀº ÀÛÀº ±Ý¼Ó¸·´ë·Î ÀÛÀº Å©±âºÎÅÍ Å« Å©±â±îÁö ´Ù¾çÇÑ Å©±â°¡ À־ ¿ì¼± ÀÛÀº ¸·´ë·Î ½ÃÀÛÇÏ¿© Á¡Á¡ Å« Å©±âÀÇ ¸·´ë¸¦ Àڱøñ¿¡ ³Ö¾î¼­ ÀڱøñÀ» È®Àå½ÃŲ´Ù. ¼­¼­È÷ È®Àå½Ãų ¶§´Â Laminaria tent¸¦ ¸ñ°ü¿¡ »ðÀÔÇϴ ¹æ¹ýÀ» »ç¿ëÇÑ´Ù. Laminaria tent¶õ ÇØÃʷΠ¸¸µç ÀÛÀº ¸·´ë·Î ¼öºÐÀ» Èí¼öÇϸé Á¡Á¡ ´Ã¾î³ª´Â ¼ºÁúÀÌ ÀÖ´Ù. À̰ÍÀ» ÀÚ±ÃÀÇ ¸ñ¿¡ ³ÖÀ¸¸é À̰ÍÀÌ ¼öºÐÀ» Èí¼öÇÏ¿© ´Ã¾î³ª¹Ç·Î ÃµÃµÈ÷ ÀÚ±ÃÀÇ ¸ñÀÌ ´Ã¾î³­´Ù. ÀڱøñÀÌ ÃæºÐÈ÷ ´Ã¾î³ª¸é ±× ¼ÓÀ¸·Î ³¡ÀÌ ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ ³Ö¾î¼­ ÀڱüÓÀÇ º´º¯À̳ª ÀӽŵȠžƸ¦ ±Ü¾î³»´Âµ¥ ¿©±â¿¡ »ç¿ëµÇ´Â ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ Å¥·¿À̶ó°í ÇÑ´Ù. Ãʱâ ÀÓ½ÅÁßÀý Áï À¯»ê°ú °°Àº ÀӽŰú °ü·ÃµÈ °æ¿ì»Ó¸¸ ¾Æ´Ï¶ó, ºñÀӽŠÀÚ±ÃÀÇ Àڱ󻸷Á¶Á÷ÀǠäÃë ¹× Á¦°Å¸¦ À§Çؼ­µµ ÇàÇØÁö´Â ¼ö±âÀÌ´Ù. À̴ ¿øÄ¢ÀûÀ¸·Î ¸¶ÃëÇÏ¿¡ ½Ç½ÃµÇ´Â °ÍÀ¸·Î Àڱøñ°üÀ» È®ÀåÇÏ°í ±â±¸·Î Àڱà³»¿ë¹°À» Á¦°ÅÇϰí Å¥·¿À¸·Î Àڱ󻺮À» ±ú²ýÀÌ ÇÑ´Ù. ÀÚ±Ãõ°øÀ̳ª ÀڱøñÀÇ ÆÄ¿­ µîÀÇ À§ÇèÀÌ µû¸£¸ç, ¼ö¼úÈÄ °¨¿° ¶Ç´Â ÃâÇ÷ µî¿¡ ´ëÇÑ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù.
¿µ¹® venereal disease, sexually transmitted diseases ÇÑ±Û ¼ºº´
¼³¸í   
  º¸ÆíÀûÀ¸·Î ¼º±³ ¶Ç´Â ¼º±âÁ¢ÃË¿¡ ÀÇÇØ °É¸®´Â Á¢ÃË Àü¿°º´À¸·Î ¸Åµ¶, ÀÓÁú, ¹«¸¥±Ë¾ç, »ô±¼À°¾ÆÁ¾ µîÀ» ¸»ÇÑ´Ù. Ä¡·á´Â ¿øÀαտ¡ µû¸¥ ÀûÀýÇÑ Ç×»ý¿ä¹ýÀÌ´Ù.
¿µ¹® psychosomatic diseases ÇÑ±Û Á¤½Å½ÅüÁúȯ
¼³¸í   
  ¿©·¯ °¡Áö Á¤½ÅÀûÀΠ¿øÀο¡ ÀÇÇÑ ½Åü Áõ»óÀ» Æ¯Â¡À¸·Î Çϴ Á¤½ÅÁúȯ°ú ½Åü ÁúȯÀǠȥÇÕÇüÀ» À̸£´Â ¸»·Î, Á¤½Å ÁúȯÀÇ ¿©·¯ °¡Áö Áõ»óÀÌ ½Åü Áõ»óÀ¸·Î ¹ßÇöµÇ´Â ÁúȯÀÌ´Ù. ½Åü Áõ»óÀº ¿©·¯ ´Ù¾çÇÑ Àå±â°¡ °ü¿©Çϰųª ¶Ç´Â ÇÑ Àå±â¸¸ °ü¿©ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • communicable
    Àü¿°-
  • communicable disease
    Àü¿°º´
  • communicable disease control
    Àü¿°º´°ü¸®
  • communicable period
    Àü¿°±â
  • legal communicable disease
    ¹ýÁ¤Àü¿°º´
  • reported communicable disease
    ½Å°íµÈÀü¿°º´
  • accidental exposure
    »ç°íÇÇÆø, »ç°í³ëÃâ
  • anxious and fearful personality
    ºÒ¾È°øÆ÷ÀΰÝ
  • arch and band appliance
    Ȱ¶ìÀåÄ¡
  • acute exposure
    ±Þ¼º³ëÃâ
  • bilateral cleft lip and palate
    ¾çÂÊÀÔ¼úÀÔõÀå°¥¸²Áõ, ¾çÃø±¸¼ø±¸°³¿­
  • bread-and-butter pericarditis
    »§¹öÅ͸ð¾ç½ÉÀ帷¿°
  • complementary and alternative medicine
    º¸Ãæ´ë¾ÈÀÇÇÐ, º¸¿Ï´ëüÀÇÇÐ
  • cumulative glycemic exposure
    ´©Àû°íÇ÷´ç³ëÃâ
  • Center for Disease Control and Prevention
    Áúº´°ü¸®¿¹¹æ¼¾ÅÍ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diphteria and tetanus toxoids and acellular pert vaccine
    °³·®µðÇÇÆ¼
  • kidney ureter and bladder
    ÄáÆÏ¿ä°ü¹æ±¤´Ü¼øÃÔ¿µ
  • dilatation and curettage
    Àڱñܾ¼ú, ÀÚ±Ã¼ÒÆÄ¼ú
  • peritoneal oocyte and sperm transfer
    »ý½Ä¼¼Æ÷º¹°­³»À̽Ä, »ý½Ä¼¼Æ÷º¹°­³»Àü´Þ
  • contact
    Á¢ÃË, Á¢ÃË-
  • proximal contact
    ÀÎÁ¢
  • allergic contact dermatitis
    ¾Ë·¹¸£±âÁ¢ÃËÇǺο°
  • photoallergic contact dermatitis
    ±¤¾Ë·¹¸£±âÁ¢ÃËÇǺο°
  • exposure
    ³ëÃâ
  • occupational exposure
    Á÷¾÷³ëÃâ
  • public exposure
    °øÁßÇÇÆø, °øÁß³ëÃâ
  • radiation exposure
    ¹æ»ç¼±³ëÃâ
  • sun exposure
    Àϱ¤³ëÃâ
  • contact urticaria syndrome
    Á¢Ã˵ε巯±âÁõÈıº
  • exposure time
    ³ëÃâ½Ã°£, Æø·Î½Ã°£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • communicable
    Àü¿°-
  • communicable disease
    Àü¿°º´
  • communicable period
    Àü¿°±â
  • communicable disease control
    Àü¿°º´°ü¸®
  • legal communicable disease
    ¹ýÁ¤Àü¿°º´
  • reported communicable disease
    ½Å°íµÈÀü¿°º´
  • accidental exposure
    »ç°íÇÇÆø, »ç°í³ëÃâ
  • acute exposure
    ±Þ¼ºÇÇÆø, ±Þ¼º³ëÃâ
  • chronic exposure
    ¸¸¼ºÇÇÆø, ¸¸¼º³ëÃâ
  • cumulative glycemic exposure
    ´©Àû°íÇ÷´ç³ëÃâ
  • exposure rate constant
    ÇÇÆø·ü»ó¼ö
  • double exposure technique
    Áߺ¹¿¢½º¼±ÃÔ¿µ¼ú
  • exposure dose
    Æø·Î¼±·®
  • exposure
    ³ëÃâ
  • exposure keratitis
    ³ëÃâ°¢¸·¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hoof and mouth disease =foot and mouth d.
    ±¸Á¦(¿ª)(Ï¢ð´æ¹) º´.
  • Infectious Diseases Society of America
    ¹ÌÁÖ°¨¿°º´Çùȸ
  • accidental exposure
    »ç°í½ÃÇÇÆø, °ú½ÇÇÇÆø
  • acute exposure
    ±Þ¼ºÇÇÆø
  • allergic diseases
    ¾Ë·¹¸£±â(¼º) Áúȯ
  • allergic diseases
    ¾Ë·¹¸£±â(¼º) Áúȯ.
  • hypertensive diseases
    °íÇ÷¾Ð¼º Áúȯ.
  • prolonged exposure
    Àå±â³ëÃâ.
  • public exposure
    °øÁßÇÇÆø
  • Contact lens
    ÄÜÅÃÆ®·»Áî
  • affective contact
    Á¤µ¿Àû Á¢ÃË(¡­ïÈõº).
  • allergic contact dermatitis
    ¾Ë·¹¸£±â Á¢ÃËÇǺο°( ïÈõºù«Ý±æú)
  • allergy, contact
    Á¢Ã˼º ¾Ë·¹¸£±â
  • arc of contact
    Á¢Ã˸é, Á¢ÃËÆø
  • hard contact lens
    ÇϵåÄÜÅÃÆ®·»Áî, °æ¼ºÄÜÅÃÆ®·»Áî
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reported communicable diseases
    °èÃâÀü¿°º´.
  • communicable
    Àü¿°¼ºÀÇ.
  • communicable disease
    Àü¿°º´
  • communicable disease control
    Àü¿°º´°ü¸®(ÊÙË´Ëö), Àü¿°º´¿¹¹æ.
  • legal communicable disease
    ¹ýÁ¤Àü¿°º´(ËÑËøËøËçËÓ).
  • allergic diseases
    ¾Ë·¹¸£±â(¼º) Áúȯ.
  • allergic diseases
    ¾Ë·¹¸£±â(¼º) Áúȯ
  • dentition diseases
    »ýÄ¡Áúȯ(ßæöÍòðü´).
  • diseases subject to regulations
    ±ÔÄ¢´ë»ó Áúȯ.
  • food borne diseases
    ½Äǰ¸Å°³¼º Áúȯ.
  • hypertensive diseases
    °íÇ÷¾Ð¼º Áúȯ.
  • kidney,cystic diseases of medulla
    ½Å¼öÁú³¶¼ºº´º¯(½Å¼öÁúÒ¥àõܻܨ)
  • law of prophylaxis for infectious diseases
    Àü¿°º´¿¹¹æ¹ý(ËøËçËÓËçËÑËÑ).
  • periodontal diseases
    Ä¡ÁÖÁúȯ(öÍñ²òðü´).
  • rickettsial diseases
    ¸®ÄÉÄ¡¾Æº´(¡­Ü»).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Contact area
    ´ê´ÂºÎºÐ
    [¿¾ ¿ë¾î] Á¢Ã˸é
  • Tendon sheath of abductor longus and extenor brevis
    ±ä¾öÁö¹ú¸²±Ù°úªÀº¾öÁöÆï±ÙÈûÁÙÁý
    [¿¾ ¿ë¾î] À幫Áö¿ÜÀü±Ù ¹× ´Ü¹«Áö½Å±Ù°ÇÃÊ
  • Lymph nodes of head and neck
    ¸Ó¸® ¹× ¸ñ¸²ÇÁÀý
    [¿¾ ¿ë¾î] µÎ°æºÎÀÓÆÄÀý
  • White matter (Tracts and Fascicles)
    ¹é»öÁú(½Å°æ·Î¿Í ½Å°æ´Ù¹ß)
    [¿¾ ¿ë¾î] ¹éÁú
  • Fold and fossa
    º¹¸·ÁÖ¸§°ú º¹¸·¿À¸ñ
    [¿¾ ¿ë¾î] º¹¸·ÁÖ¸§°ú º¹¸·¿Í
  • Tendon sheath of extensor digitorum and extensor indicis
    ¼Õ°¡¶ôÆï±Ù°úÁý°ÔÆï±ÙÈûÁÙÁý
    [¿¾ ¿ë¾î] Áö½Å±Ù ¹× ½ÃÁö½Å±Ù°ÇÃÊ
  • Sections of thalamus and metathalamus
    ½Ã»ó ¹× ½Ã»óÈĺÎÀÇ ´Ü¸é
    [¿¾ ¿ë¾î] ½Ã»ó ¹× ½Ã»óÈĺÎÀÇ ´Ü¸é
  • Tracts and fascicles of thalamus
    ½Ã»óÀÇ ½Å°æ·Î ¹× ½Å°æ´Ù¹ß
    [¿¾ ¿ë¾î] ½Ã»ó·Î ¹× ½Ã»ó¼Ó
  • Tracts and fascicles of hypothalamus
    ½Ã»óÇϺÎÀÇ ½Å°æ·Î ¹× ½Å°æ´Ù¹ß
    [¿¾ ¿ë¾î] ½Ã»óÇϺηΠ¹× ½Ã»óÇϺμÓ
  • Period of mature neural groove and immature somite
    ½Å°æ°í¶û¼º¼÷ ¹× ¸öºÐÀý¹Ì¼º¼÷±â
    [¿¾ ¿ë¾î] ½Å°æ±¸Çü¼ºÈÄ±â ¹× Ã¼ÀýÇü¼ºÀü±â
  • Medial and inferior surface
    ¾ÈÂÊ¸é ¹× ¾Æ·¡¸é
    [¿¾ ¿ë¾î] ³»Ãø¸é°ú Çϸé
  • Sacral nerves and coccygeal nerve
    ¾ûÄ¡½Å°æ ¹× ²¿¸®½Å°æ
    [¿¾ ¿ë¾î] õ°ñ½Å°æ ¹× ¹Ì°ñ½Å°æ
  • Lobar and segmental bronchi
    ¿±±â°üÁö¿Í ±¸¿ª±â°üÁö
    [¿¾ ¿ë¾î] ¿±±â°üÁö¿Í ±¸±â°üÁö
  • Muscles of palate and fauces
    ÀÔõÀå ¹× ¸ñ±¸¸Û±ÙÀ°
    [¿¾ ¿ë¾î] ±¸°³ ¹× ±¸Çù±Ù
  • Muscles of palate and fauces
    ÀÔõÀå ¹× ¸ñ±¸¸Û±ÙÀ°
    [¿¾ ¿ë¾î] ±¸°³±Ù ¹× ±¸Çù±Ù
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • exposure dose
    ³ëÃâ·®(ÖÚõóÕá)
  • gaseous exposure method
    °³½º ³ëÃâ¹ý(ÖÚõóÛö)
  • contact activation cofactor
    "Á¢ÃËȰ¼º º¸ÀÎÀÚ(ïÈõºüÀàõÜÍì×í­), (ÔÒ) high molecular weight kininogen"
  • contact factor
    "Á¢ÃËÀÎÀÚ(ïÈõºì×í­), (ÔÒ) Hageman factor"
  • contact guidance
    Á¢Ã˾ȳ»(ïÈõºäÐÒ®)
  • contact hypersensitivity
    Á¢Ã˰ú¹ÎÁõ(ïÈõºÎ¦ÚÂñø)
  • contact inhibition
    Á¢ÃËÀúÇØ(ïÈõºîÁúª)
  • contact map
    Á¢ÃËÁöµµ(ïÈõºò¢Óñ)
  • contact surface
    Á¢Ã˸é(ïÈõºØü)
  • ball and stick model
    °ø ¸·´ë ¸ðµ¨
  • breakage and reunion model
    Àý´ÜÀç°áÇÕ(ï·Ó¨î¢Ì¿ùê)¸ðµ¨
  • cut and patch repair
    Àß¶ó±é±â ¼öº¹(áóÜÖ) (ÔÒ) excision repair
  • Dean and Webb method
    µò°ú¿þºê ¹ý(Ûö)
  • Jacob and Monod hypothesis
    Àð°ö¡¤¸ð³ë ¼³(àã)
  • knife and fork model
    ³ªÀÌÇÁÆ÷Å© ¸ðµ¨
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • communicable disease
    Àü¿°º´
  • double exposure technique
    Áߺ¹X¼±ÃÔ¿µ¼ú
  • exposure
    ³ëÃâ, Æø·Î, Á¶»ç
  • exposure time
    ³ëÃâ½Ã°£, Á¶ ½Ã°£
  • contact
    Á¢ÃË
  • contact compound scan
    Á¢Ã˺¹ÇÕ½ºÄµ
  • contact dermatitis
    Á¢ÃËÇǺο°
  • contact irradiation
    ±ÙÁ¢Á¶»ç¹ý
  • contact radiography
    ±ÙÁ¢ÃÔ¿µ¼ú
  • contact scan
    Á¢Ã˽ºÄµ
  • ball and socket joint
    Àý±¸°øÀ̰üÀý
  • ENT [=ear, nose and throat]
    À̺ñÀÎÈİúÇÐ
  • growth and development
    ¼ºÀå°ú ¹ßÀ°
  • infant and child
    ¿µÀ¯¾Æ, À¯¼Ò¾Æ
  • intake and output
    ¼·Ãë¿Í ¹è¼³
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CD cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise...
CDSC Communicable Diseases Surveillance Centre [London]
ICD I-cell disease; immune complex disease; implantable cardioverter defibrillator; impulse-control diso...
CDC calculated date of confinement; cancer diagnosis center; capillary diffusion capacity; cell division...
CCDC Canadian Communicable Disease Center
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CDSC Communicable Disease Surveillance Centre
NCD non-communicable disease
ACD Allergic contact dermatitis
AID Auto-immune diseases
CVD Collagen vascular diseases
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • Z20
    Contact with and exposure to communicable diseases
    Àü¿°¼º Áúȯ¿¡ Á¢ÃË ¹× ³ëÃâ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • communicable
    Àü¿°¼ºÀÇ
  • International Classification of Diseases
    ±¹Á¦Áúº´ºÐ·ù
  • legal communicable disease
    ¹ýÁ¤ Àü¿°º´
    Àü¿°º´ ¿¹¹æ¹ý Á¦2Á¶ 1Ç׿¡¼­ ¿­°Å ±ÔÁ¤Çϰí ÀÖ´Â Àü¿°º´. Á¦1Á¾, Á¦2Á¾ ¹× Á¦3Á¾À¸·Î ³ª´©¾îÁø´Ù. 93³â 12¿ù ¼öÁ¤, °áÁ¤µÈ ¹ýÁ¤ Àü¿°º´Àº ¸ðµÎ 28Á¾ÀÌ´Ù. Áï, Á¦1Á¾Àº ÄÝ·¹¶ó, Æä½ºÆ®, ¹ßÁøÆ¼Çª½º, ÀåÆ¼Çª½º, ÆÄ¶óƼǪ½º, µðÇÁÅ׸®¾Æ, ¼¼±Õ¼º ÀÌÁú, Ȳ¿­, Á¦2Á¾Àº Æú¸®¿À, ¹éÀÏÇØ, È«¿ª, À¯Ç༺ ÀÌÇϼ±¿°, ÀϺ» ³ú¿°, °ø¼öº´, ¸»¶ó¸®¾Æ, ¹ßÁø¿­, ¼ºÈ«¿­, Àç±Í¿­, ¾Æ¸Þ¹Ù¼º ÀÌÁú, ¼ö¸· ±¸±Õ¼º ¼ö¸·¿°, À¯Ç༺ ÃâÇ÷¿­, ÆÄ»ódz, ÈÄõ¼º ¸é¿ª °áÇÌÁõ, ·¾Å佺ÇǶóÁõ, ¾²¾²°¡¹«½Ã º´, Á¦3Á¾Àº °áÇÙ, ¼ºº´, ³ªº´À¸·Î µÇ¾î ÀÖ´Ù. Àü¿°º´ ¿¹¹æ¹ýÀº ¹ýÁ¤ Àü¿°º´¿¡ ´ëÇÑ ÀÇ»ç, È£ÁÖ, ¼¼´ëÁÖ, ±âŸ °¢ ±â°üÀÇ ±â°üÀåÀ̳ª °æ¿µÀÚ, ±º ºÎ´ëÀå µîÀÇ ½Å°í ¹× º¸°í Àǹ«¿Í °Ç°­ Áø´Ü, ¿¹¹æ Á¢Á¾, °Ý¸®, ÀÔ¿ø Á¶Ä¡, °¢Á¾ ¿¹¹æ Á¶Ä¡ µîÀ» ±ÔÁ¤Çϰí ÀÖ´Ù.
  • rickettsial diseases
    ¸®ÄÉÄ¡¾Æ º´
  • acute exposure
    ±Þ¼º ÇÇÆø
    ¹æ»ç¼± °Ç°­°ü¸®Çлó »ç¿ëµÇ´Â ¿ë¾îÀÌ°í ¹æ»ç¼± »ç°í µî, ºñ±³Àû ªÀº ½Ã°£¿¡ °íü°¡ ÇÇÆøÇÏ´Â °ÍÀ» ¸»ÇÑ´Ù. Á÷¾÷ÀûÀ¸·Î ¾Æ¹«·¡µµ ÇÇÇÒ ¼ö ¾ø´Â ÇÇÆøÀ̳ª ½ºÆ®·ÐƬÀÇ »À¿¡ ´ëÇÑ Ä§Âø µî Àå¹Ý°¨±âÀÇ ¹æ»ç¼± µ¿À§¿ø¼Ò°¡ ¸ö ¾È¿¡ µé¾î°£ °æ¿ìÀÇ ÇÇÆøÀ» ¸¸¼º ÇÇÆøÀ̶ó°í ¸»Çϴµ¥ ´ëÇØ¼­ À̰°ÀÌ ¸»ÇÑ´Ù.
  • chemical exposure
    È­ÇÐÀû ³ëÃâ
  • chronic exposure
    ¸¸¼º ³ëÃâ
  • double exposure technique
    Áߺ¹ X¼± ÃÔ¿µ¼ú
  • ensitization 1. administration of antigen to induce a primary immune response; priming; immunization. 2. exposure to allergen that results in the development of hypersensitivity. 3. the coating of erythrocytes with antibody so that they are subject to lys
    ³»¹ø
    ƯÈ÷ ¾È°Ë ¿¬ÀÇ.
  • exposure dose
    Á¶»ç·®
  • exposure threshold
    ³ëÃâ ÇѰèÄ¡
  • exposure time per session
    ´ÜÀ§´ç ³ëÃ⠽ð£
  • long-term exposure
    Àå±â ³ëÃâ
  • maximum permissible exposure
    ÃÖ´ë Çã¿ë ³ëÃâ
  • mercury exposure
    ¼öÀº¿¡ÀÇ ³ëÃâ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
Control of Communicable Diseases in Man The internationally recognised authoritative manual now in the 15th (1990) edition, published by the American Public Health Association.
(05 Mar 2000)
communicable Capable of being communicated or transmitted; said especially of disease.
(05 Mar 2000)
communicable disease Any disease that is transmissible by infection or contagion directly or through the agency of a vector.
(05 Mar 2000)
communicable disease control Programs of surveillance designed to prevent the transmission of disease by any means from person to person or from animal to man.
(12 Dec 1998)
hemic and lymphatic diseases Haematologic diseases and diseases of the lymphatic system collectively. Hemic diseases include disorders involving the formed elements (e.g., erythrocyte aggregation, intravascular) and chemical components (e.g., blood protein disorders); lymphatic diseases include disorders relating to lymph, lymph nodes, and lymphocytes.
(12 Dec 1998)
skin and connective tissue diseases A collective term for diseases of the skin and its appendages and of connective tissue.
(12 Dec 1998)
neonatal diseases and abnormalities Diseases existing at birth and often before birth, regardless of causation. Of these congenital diseases, those characterised by structural deformities are termed abnormalities.
(12 Dec 1998)
nutritional and metabolic diseases A collective term for nutritional disorders (result of poor assimilation or utilization of food) and metabolic disorders (result of poor metabolism or inherited enzyme abnormality).
(12 Dec 1998)
injuries, poisonings, and occupational diseases Disorders representing collectively the results of assault by external forces, rather than by organic or physiologic dysfunction or by pathogens.
(12 Dec 1998)
urologic and male genital diseases A collective term for urinary tract diseases in male and female and diseases of the male genitalia.
(12 Dec 1998)
maternal exposure Exposure of the female parent, human or animal, to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals that may affect offspring. It includes pre-conception maternal exposure.
(12 Dec 1998)
maximum permissible exposure level The highest level of exposure to a substance, usually noxious, in the environment or during diagnostic and therapeutic procedures, that a body can tolerate without injury.
(12 Dec 1998)
paternal exposure Exposure of the male parent, human or animal, to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals that may affect offspring.
(12 Dec 1998)
permissible exposure limit An occupational health standard to safeguard workers against dangerous contaminants in the workplace.
(05 Mar 2000)
prenatal exposure delayed effects Delayed effects on offspring of maternal or foetal prenatal exposure to drugs, radiation and other physical agents, manipulation, nutrition, stress, etc.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • communicable
    Àü´ÞÇÒ ¼ö ÀÖ´Â
  • communicable
    Àü´ÞÇÒ ¼ö ÀÖ´Â;Àü¿°¼ºÀÇ;¸»Çϱâ ÁÁ¾ÆÇÏ´Â;~ness
  • exposure
    ³ëÃâ
  • double exposure
    (»ç)ÀÌÁß ³ëÃâ
  • exposure
    ¹ö·ÁµÒ;(Áý,¹æÀÇ)Çâ;³ëÃâ;Æø·Î;Àû¹ß;(¾î¸°¾ÖÀÇ)À¯±â
  • exposure index
    ³ë±¤Áö¼ö
  • exposure meter
    ³ëÃâ°è
  • indecent exposure
    (¹ý)°ø°³Àû ¿Ü¼³ÁË
  • time exposure
    ŸÀÓ ³ëÃâ(ÀÇ »çÁø)
  • contact
    Á¢ÃË,±³Á¦,¿¬¶ôÇÏ´Ù,Á¢ÃËÇÏ´Ù
  • contact
    Á¢ÃË;¸Â´êÀ½(touching);±³Á¦;Ä£±³(associations)¿¬¶ô(À» ÃëÇÔ);¿¬ÁÙ(connection);Á¢ÃË;È¥¼±;»óÁ¢;Á¢ÃË;º¸±Õ¿ëÀÇÀÚ;Á¢ÃË(°¨);Á¢Àü;(ºñÇà±â¿¡ ÀÇÇÑ Áö»ó ÀüÁøºÎ´ë¿ÍÀÇ)¿¬¶ô;À°¾È¿¡ ÀÇÇÑ Áö»ó°üÂû;±³½Å;(»ó¾÷Àû¸ñÀûÀ¸·Î)±³¼·Çϰí ÀÖ´Â »ç¶÷;Á߰迪ÇÒÀ» ÇÒ¼öÀÖ´Â »ç¶÷;=CONTACT L
  • contact action
    Á¢ÃËÀÛ¿ë
  • contact agent
    Ã˸Å;Á¢ÃËÁ¦(catalyzer)
  • contact approach
    À¯½Ã°è ÁøÀÔ
  • contact breaker
    (Àü·ùÀÇ) Â÷´Ü±â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á